Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Advancement in study on long n...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Advancement in study on long non⁃coding RNA and trastuzumab resistance of HER2 positive breast cancer

Advancement in study on long non⁃coding RNA and trastuzumab resistance of HER2 positive breast cancer

Bibliographic Details
Main Author: CAO Wei, CHEN Xiaosong, SHEN Kunwei
Format: Article
Language:zho
Published: Editorial Office of Journal of Surgery Concepts & Practice 2020-05-01
Series:Waike lilun yu shijian
Online Access:https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1595690316607-924127764.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1595690316607-924127764.pdf

Similar Items

  • HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
    by: Shuai Li, et al.
    Published: (2020-12-01)
  • The role of HER4 in relation to trastuzumab resistance and prognosis in HER2 positive breast cancer
    by: Mohd Nafi, SN
    Published: (2014)
  • Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients
    by: Shuai Li, et al.
    Published: (2021-07-01)
  • Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
    by: Ami Hori, et al.
    Published: (2019-08-01)
  • Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
    by: Xin Li, et al.
    Published: (2018-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs